Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2022 Earnings Call Transcript
Juli Miller: Good morning and welcome to Adaptimmune's conference call to discuss our third quarter 2022 financial results and business update.
Source: insidermonkey.com
Stay updated with breaking news from Third Quarter Call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Juli Miller: Good morning and welcome to Adaptimmune's conference call to discuss our third quarter 2022 financial results and business update.